Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency.
about
General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnoverMyopathic form of very-long chain acyl-coa dehydrogenase deficiency: evidence for temperature-sensitive mild mutations in both mutant alleles in a Japanese girl.CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE.Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screeningTreatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglycerideA Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyMolecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiencyNeuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.Rhabdomyolysis as a presenting manifestation of very long-chain acyl-coenzyme a dehydrogenase deficiency.Successful Treatment of Cardiomyopathy due to Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: First Case Report from Oman with Literature Review.MCT oil-based diet reverses hypertrophic cardiomyopathy in a patient with very long chain acyl-coA dehydrogenase deficiency.Perioperative management of a child with very-long-chain acyl-coenzyme A dehydrogenase deficiency.Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.Kruppel-like factor 15 is required for the cardiac adaptive response to fasting.
P2860
Q28186172-DD16E27A-4A95-4B73-BFFC-646E01129157Q31832846-A6449A41-91E8-4C0A-B133-DBBF4971A283Q34002504-FE42D7A6-B26F-4A45-8367-0739F528066BQ34065034-BC3DAACE-3570-47AE-A054-81BEB9628F9EQ34793960-263D0F59-4288-4737-9045-16AC5090935AQ35558483-57E19796-D221-4E1A-9200-4F6D6877E167Q36771892-79136EB2-A924-4230-B723-1E8AC3C828C9Q37329228-5D027FFB-CBFB-437F-88EF-1CCFBD882C17Q37694205-60E56C5B-B63B-4DE1-A068-F916B8F17D2FQ38138574-642E52A7-0799-4B80-A3E3-E18FCD6A6C8CQ42130412-A3A4F68F-A2D2-41BA-BE57-485EF8AF80BEQ43907901-46EA7742-5BF9-4AE4-9679-EF67BB326D30Q46387585-95D46FBF-CB45-45A9-8667-7372AE01A6A9Q48097578-EED80BD6-9841-4085-962D-DB2D0C838383
P2860
Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@en
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@nl
type
label
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@en
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@nl
prefLabel
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@en
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@nl
P2093
P1476
Reversal of severe hypertrophi ...... me A dehydrogenase deficiency.
@en
P2093
Hashimoto T
Rockenmacher S
Varvogli L
P304
P356
10.1016/S0022-3476(98)70228-8
P407
P577
1998-08-01T00:00:00Z